SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Centura Software Corporation (NASDAQ:CNTR)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jack M. Moriss who wrote (2235)2/2/1998 1:18:00 AM
From: Robert Williams  Read Replies (3) of 2428
 
Jack & Max90,
There are a number of companies that have executed a reverse split when it was appropriate and have thereafter had substantial share price appreciation.

Medicis (MDRX) is a solid example. Appx. 2+ years ago Medicis was at .25 a share. Upon execution of their business plan they reached profitability and doubled to .50 a share. Shortly thereafter they performed a 14 for 1 reverse split. Since that time they have not only led NASDAQ one year in total price performance but have had their share price appreciate by appx. one thousand %. That is not a miss-statement. Medicis had a business plan that was strategically viable.

Bentley Pharmaceuticals (BNT) is another intriguing company that has performed a reverse split. They are in the same industry as Medicis and they have a similar business model. Since their 10 for 1 reverse, Bentley has signed a significant letter of intent with a multi-national pharmaceutical, executed a Voluntary warrant conversion, raising appx. $10 million (converting 70% of all Class A warrants) for operations and acquisitions, won a judgement for appx. $8 million dollars, and had The Dreyfus Fund file a 13G (Jan. 98) that they have recently acquired more than 10% of the outstanding stock. All of this in a post reverse split environment. Bentley's share price is appx. 2.37 a share. They have appx. 8.4 million shares outstanding.

I am not suggesting that Medicis and Bentley are clones, or that Bentley will have rapid share price appreciation as Medicis did, only that a reverse split can provide the basis for real accomplishments and potentially result in share price appreciation.

It is important to understand the basis for a company performing a reverse split. If the company has a strong engine for growth and is shortly to inaugurate profitability a reverse split is a prudent course of action. However, to do so simply to preserve Nasdaq or listed status (as has been recently proffered on this thread as a basis for Centura's decision) is not only short-sighted but an open invitation to anyone who would like to short the stock. I can assure you that if Centura performs a reverse for this reason that I will examine joining the shorts.

Centura's key to success is continued solid growth and profitability. Those who are currently holding positions may be in a little early however the recently announced German contract is not only appealing, it may be a watershed event. Time will tell but barring a general market meltdown Centura appears oversold at a dollar a share.

Best Regards,
Robert W.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext